Methylxanthine for the prevention and treatment of apnea in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Methylxanthine for the Prevention and Treatment of Apnea in Preterm Infants." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437364/all/repview. Accessed 01 May 2024.
Methylxanthine for the prevention and treatment of apnea in preterm infants. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437364/all/repview. Accessed May 1, 2024.
Methylxanthine for the prevention and treatment of apnea in preterm infants. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437364/all/repview
Methylxanthine for the Prevention and Treatment of Apnea in Preterm Infants [Internet]. In: Cochrane Abstracts. [cited 2024 May 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437364/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methylxanthine for the prevention and treatment of apnea in preterm infants
ID - 437364
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437364/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -